Hand Osteoarthritis Musculoskeletal Diseases Arthrosis of first carpometacarpal joint
Conditions
Interventions
Patients will be randomised into two groups. Each group receives an intervention, either the standard treatment in agreement with the rheumatologist or the interdisciplinary intervention. Patients ran
Sponsors
Medical University of Vienna (Austria)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients meeting the American College of Rheumatology (ACR) criteria for hand OA 2. In order not to exclude patients with hand osteoarthritis in an early stage, patients will also be eligible to participate in this study if they have bony swelling of at least one interphalangeal (IP) joint of the 2nd to 5th finger and/ or pain or bony swelling of at least one carpometacarpal (CMC) 1 joint 3. To have a potential for improvement (and motivation for adherence to the treatment), eligible patients have to be above or equal to an 11- point Likert scale of hand pain of at least 3 at two time points
Exclusion criteria
Exclusion criteria: 1. Patients with evidence of rheumatoid arthritis or any rheumatic disease other than OA 2. Furthermore, persons with elevated C-reactive protein levels (>0.5 mg/dl) as a sign of active inflammation at the test visit and/ or with soft tissue swelling of any of the finger joints on either hand 3. Patients who have received steroid injections within the last four weeks 4. Patients who have undergone hand surgery within the last year 5. Patients who plan to receive steroid injections or hand surgery during the study period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Grip strength measured using a vigorimeter at baseline and two months later | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Hand function measured by a test (sub-test of the Jebsen-Taylor-Hand-Function-Test) and a self-report questionnaire (AUSCAN) 2. Self-reported assessment of pain and satisfaction of patients with their health care and health status (on a 11-point Likert scale) Measured at baseline and two months later. | — |
Countries
Austria
Outcome results
None listed